PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $308,000 | -44.1% | 145,512 | -11.5% | 0.05% | -40.3% |
| Q3 2016 | $551,000 | +654.8% | 164,405 | +607.6% | 0.08% | +541.7% |
| Q2 2016 | $73,000 | +102.8% | 23,235 | +116.9% | 0.01% | +100.0% |
| Q1 2016 | $36,000 | -61.7% | 10,712 | -59.6% | 0.01% | -71.4% |
| Q4 2015 | $94,000 | -27.1% | 26,509 | +45.1% | 0.02% | -25.0% |
| Q1 2015 | $129,000 | +30.3% | 18,268 | +42.4% | 0.03% | +40.0% |
| Q4 2014 | $99,000 | – | 12,831 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |